1. Home
  2. VNET vs SPTX Comparison

VNET vs SPTX Comparison

Compare VNET & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VNET Group Inc.

VNET

VNET Group Inc.

SELL

Current Price

$2.56

Market Cap

1.3B

Sector

Technology

ML Signal

SELL

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

SELL

Current Price

$18.19

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
VNET
SPTX
Founded
1999
2024
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
VNET
SPTX
Price
$2.56
$18.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
15
9
Target Price
$9.88
★ $37.13
AVG Volume (30 Days)
★ 6.3M
253.7K
Earning Date
11-23-2026
11-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.70
N/A
Revenue Next Year
$21.56
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.50
$15.79
52 Week High
$14.48
$28.38

Technical Indicators

Market Signals
Indicator
VNET
SPTX
Relative Strength Index (RSI) 31.39 37.59
Support Level N/A $15.79
Resistance Level $3.80 $22.57
Average True Range (ATR) 0.36 1.47
MACD 0.02 -0.24
Stochastic Oscillator 2.69 0.00

Price Performance

Historical Comparison
VNET
SPTX

About VNET VNET Group Inc.

VNET started as AsiaCloud in 1999 and moved into the data center business, opening its first self-developed data center in 2010. The firm listed (as 21Vianet) on the Nasdaq in April 2011, subsequently changing its name to VNET Group in 2021. It originally focused on providing data center services such as colocation and cloud services to retail clients in China, but added hyperscale customers in 2019 and now counts large Chinese hyperscalers such as Alibaba Cloud, Tencent Cloud, and Huawei Cloud as customers. At the end of June 2026, it had 50,081 retail cabinets, with the majority in Beijing, Shanghai, and the Greater Bay Area. It also had 1.007 megawatts of wholesale capacity in service, with a further 585 MW under construction and a further 1.050 MW held for future development.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: